ALXO logo

ALX Oncology Holdings Inc. (ALXO)

Profile

Full Name

ALX Oncology Holdings Inc.

Ticker

NASDAQ: ALXO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 17, 2020

Indexes

Not included

Website

http://www.alxoncology.com

Employees

65

Key Details

Price

$0.54(+6.72%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.58(+31.02% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.54
    ALXO price is $0.54

    30-Day Relative Volume

    1.19
    ALXO 30-day relative volume is 1.19

    Price Performance

    Price Most recent change

    +6.72%
    ALXO price was up +6.72% on Jul 24, 2025

    Price YTD change

    -67.66%
    ALXO price is down -67.66% since January 1st

    Price 1-year change

    -91.15%
    ALXO price is down -91.15% year-on-year

    Price 3-year change

    -95.32%
    ALXO price is down -95.32% over the past 3 years

    Price Range

    Price All-time high

    $117.45
    ALXO price is currently -99.54% below its historical high of $117.45

    Price 3-year low

    $0.40
    ALXO price is currently +33.66% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $28.86M
    ALXO market capitalization is $28.86 million

    Market cap 3-year change

    -93.87%
    ALXO market capitalization is down -93.87% over the past 3 years

    Market cap All-time high

    $4.17B
    ALXO market capitalization is currently -99.31% below its historical high of $4.17 billion

    Market cap sector rank

    27.78%
    ALXO market capitalization is higher than 27.78% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.89%
    ALXO shares outstanding is up +1.89% year-on-year

    Shares Outstanding 3-Year Change

    +31.17%
    ALXO shares outstanding is up +31.17% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.99
    ALXO beta is 0.99

    200-day SMA

    $1.02
    ALXO price is currently -47.16% below its 200-day simple moving average

    50-day SMA

    $0.48
    ALXO price is currently +11.96% above its 50-day simple moving average

    RSI

    61.45
    ALXO 14-day relative strength index is 61.45

    Volume

    1.19
    ALXO 30-day relative volume is 1.19

    ATR

    $0.04
    ALXO average true range is $0.04

    10-day Historical Volatility

    64.64%
    ALXO 10-day historical volatility is 64.64%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ALXO annual revenue value is unknown

    Revenue Analysts estimate

    -
    ALXO annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ALXO annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ALXO annual revenue is unknown

    EPS

    EPS

    -$2.58
    ALXO annual earnings per share is -$2.58

    EPS Analysts estimate

    -$1.07
    ALXO annual earnings per share is currently +141.98% higher than the consensus analysts' forecast

    EPS 1-year change

    +31.02%
    ALXO annual earnings per share is up +31.02% year-on-year

    EPS Sector rank

    33.97%
    ALXO annual earnings per share is higher than 33.97% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ALXO annual gross profit value is unknown

    Gross margin

    -
    ALXO annual gross profit margin value is unknown

    Operating profit

    -$142.47M
    ALXO annual operating income is -$142.47 million

    Operating margin

    -
    ALXO annual operating profit margin value is unknown

    Net income

    -$134.85M
    ALXO annual net profit is -$134.85 million

    Net margin

    -
    ALXO annual net profit margin value is unknown

    Expenses

    Total expenses

    $142.47M
    ALXO annual total expenses is $142.47 million

    Operating expenses

    $142.47M
    ALXO annual total operating expenses is $142.47 million

    Cost of goods sold

    -
    ALXO annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $26.09M
    ALXO annual SGA is $26.09 million

    Depreciation and amortization

    $872.00K
    ALXO annual depreciation & amortization is $872.00 thousand

    Interest expense

    $1.73M
    ALXO annual interest expense is $1.73 million

    Income tax

    $0.00
    ALXO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$133.12M
    ALXO annual earnings before interest & taxes is -$133.12 million

    EBITDA

    -$132.25M
    ALXO annual EBITDA is -$132.25 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $147.78M
    ALXO annual total assets is $147.78 million

    Non current assets

    $13.42M
    ALXO annual long term assets is $13.42 million

    Current assets

    $134.35M
    ALXO annual total current assets is $134.35 million

    Cash and cash equivalents

    $17.57M
    ALXO annual cash & cash equivalents is $17.57 million

    Accounts receivable

    -
    ALXO annual accounts receivable value is unknown

    Inventory

    -
    ALXO annual inventory value is unknown

    Liabilities

    Total liabilities

    $34.16M
    ALXO annual total liabilities is $34.16 million

    Long term liabilities

    $15.66M
    ALXO annual total long term liabilities is $15.66 million

    Current liabilities

    $18.50M
    ALXO annual total current liabilities is $18.50 million

    Accounts payable

    $4.50M
    ALXO annual accounts payable is $4.50 million

    Debt

    Total debt

    $9.90M
    ALXO annual total debt is $9.90 million

    Total debt 1-year change

    +2.75%
    ALXO annual total debt is up +2.75% year-on-year

    Long term debt

    $9.47M
    ALXO annual long term debt is $9.47 million

    Short term debt

    $435.00K
    ALXO annual short term debt is $435.00 thousand

    Equity & Capital

    Shareholders equity

    $113.62M
    ALXO annual stockholders equity is $113.62 million

    Book value

    $113.62M
    ALXO annual book value is $113.62 million

    Retained earnings

    -$621.12M
    ALXO annual retained earnings is -$621.12 million

    Working capital

    $115.85M
    ALXO annual working capital is $115.85 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$121.91M
    ALXO annual cash flow from operations is -$121.91 million

    Cash from operations 1-year change

    +6.48%
    ALXO annual cash flow from operations is up +6.48% year-on-year

    Cash from investing

    $86.26M
    ALXO annual cash flow from investing activities is $86.26 million

    Cash from investing 1-year change

    +93.15%
    ALXO annual cash flow from investing activities is up +93.15% year-on-year

    Cash from financing

    $30.82M
    ALXO annual cash flow from financing activities is $30.82 million

    Cash from financing 1-year change

    -48.02%
    ALXO annual cash flow from financing activities is down -48.02% year-on-year

    CAPEX

    CAPEX

    -
    ALXO annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ALXO annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$122.36M
    ALXO annual free cash flow is -$122.36 million

    Free cash flow 1-year change

    +7.05%
    ALXO annual free cash flow is up +7.05% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ALXO annual gross profit margin value is unknown

    Operating margin

    -
    ALXO annual operating profit margin value is unknown

    Net margin

    -
    ALXO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -91.25%
    ALXO annual return on assets is -91.25%

    ROE

    -118.69%
    ALXO annual return on equity is -118.69%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ALXO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ALXO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.33
    ALXO price to book ratio is 0.33

    PB ratio Sector rank

    20.83%
    ALXO price to book ratio is higher than 20.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ALXO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ALXO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $18.22M
    ALXO enterprise value is $18.22 million

    Enterprise value Sector rank

    24.92%
    ALXO enterprise value is higher than 24.92% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.14
    ALXO EV/EBITDA is -0.14

    EV/EBITDA Sector rank

    63.94%
    ALXO EV/EBITDA is higher than 63.94% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.26
    ALXO annual current ratio is 7.26

    Quick ratio

    -
    ALXO annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.09
    ALXO annual debt to equity ratio is 0.09

    Interest coverage ratio

    -76.99
    ALXO annual interest coverage ratio is -76.99

    Risk & Stability

    Piotroski F-Score

    -
    ALXO piotroski f-score value is unknown

    Altman Z-Score

    -
    ALXO altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 21, 25 UBS
    Buy
    May 9, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Stifel
    Hold
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Mar 6, 25 Piper Sandler
    Overweight
    Mar 6, 25 Jefferies
    Buy
    Jan 27, 25 UBS
    Buy
    Jan 24, 25 HC Wainwright & Co.
    Buy
    Jan 24, 25 Cantor Fitzgerald
    Overweight
    Dec 19, 24 Jefferies
    Hold

    Institutional Ownership

    Screeners with ALXO included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for ALX Oncology Holdings Inc.?
    • Does ALX Oncology Holdings Inc. pay dividends?
    • What sector is ALX Oncology Holdings Inc. in?
    • What industry is ALX Oncology Holdings Inc. in?
    • What country is ALX Oncology Holdings Inc. based in?
    • When did ALX Oncology Holdings Inc. go public?
    • Is ALX Oncology Holdings Inc. in the S&P 500?
    • Is ALX Oncology Holdings Inc. in the NASDAQ 100?
    • Is ALX Oncology Holdings Inc. in the Dow Jones?
    • When was ALX Oncology Holdings Inc.'s last earnings report?
    • When does ALX Oncology Holdings Inc. report earnings?

    What is the ticker symbol for ALX Oncology Holdings Inc.?

    The ticker symbol for ALX Oncology Holdings Inc. is NASDAQ:ALXO

    Does ALX Oncology Holdings Inc. pay dividends?

    No, ALX Oncology Holdings Inc. does not pay dividends

    What sector is ALX Oncology Holdings Inc. in?

    ALX Oncology Holdings Inc. is in the Healthcare sector

    What industry is ALX Oncology Holdings Inc. in?

    ALX Oncology Holdings Inc. is in the Biotechnology industry

    What country is ALX Oncology Holdings Inc. based in?

    ALX Oncology Holdings Inc. is headquartered in United States

    When did ALX Oncology Holdings Inc. go public?

    ALX Oncology Holdings Inc.'s initial public offering (IPO) was on July 17, 2020

    Is ALX Oncology Holdings Inc. in the S&P 500?

    No, ALX Oncology Holdings Inc. is not included in the S&P 500 index

    Is ALX Oncology Holdings Inc. in the NASDAQ 100?

    No, ALX Oncology Holdings Inc. is not included in the NASDAQ 100 index

    Is ALX Oncology Holdings Inc. in the Dow Jones?

    No, ALX Oncology Holdings Inc. is not included in the Dow Jones index

    When was ALX Oncology Holdings Inc.'s last earnings report?

    ALX Oncology Holdings Inc.'s most recent earnings report was on May 8, 2025

    When does ALX Oncology Holdings Inc. report earnings?

    The next expected earnings date for ALX Oncology Holdings Inc. is August 8, 2025
    On this page